2016 Anti-Doping Rule Violations (ADRVs) Report / World Anti-Doping Agency (WADA). - Montreal : WADA, 2018.
- Report compiled based on cases received by WADA before 31 December 2017

This is the fourth year that WADA publishes the ADRVs Report. The Report illustrates doping offences committed under the World Anti-Doping Code in 2016.

The Report includes the decisions of all adverse analytical findings (AAFs) for which the samples were collected by anti-doping organizations (ADOs) in 2016 and the results are reported in ADAMS as well as non-analytical anti-doping rule violations for decisions rendered in 2016. Discrepancy from ADOs’ published statistics may occur due to different reporting criteria.

The ADRVs Report is broken down as follows:

• An Introduction and an Executive Summary, which provide an overview of the Report and highlight the key observations of the 2016 ADRVs Report.
• Sections 1 and 2 present the results management outcomes (including ADRVs) of all AAFs detected by WADA-accredited Laboratories for samples collected from athletes in- and out-of-competition in 2016. They are presented by sport, discipline (Section 1) and testing authority (Section 2).
• Section 3 includes ADRVs that resulted from non-analytical findings committed by athletes (presented by sport and nationality) and by athlete support personnel (presented by nationality).
• Section 4 indicates the total number of ADRVs from athletes in 2016, which includes AAFs that resulted in an ADRV plus all non-analytical ADRVs. The data is presented by sport and nationality. The information is further broken down into type of samples (urine or blood), type of test (in- or out-of-competition) and athlete gender.

Contents:

Introduction
Executive Summary
Section 1: Outcomes of 2016 AAFs by Sport Category
Section 2: Outcomes of 2016 AAFs by Testing Authority Category
Section 3: Report of 2016 Non-Analytical ADRVs
Section 4: Report of 20165 Total Analytical and Non-Analytical ADRVs

2016 Anti-Doping Testing Figures Report / World Anti-Doping Agency (WADA). - Montreal : WADA, 2017

Contents:

- Executive Summary - pp. 2-9 (7 pages)
- Laboratory Report -– pp. 10-36 (26 pages)
- Sport Report - pp. 37-150 (113 pages)
- Testing Authority Report - pp. 151-287 (136 pages)
- ABP Report-Blood Analysis - pp. 288-323 (35 pages)

2017 Anti-Doping Rule Violations (ADRVs) Report / World Anti-Doping Agency (WADA). - Montreal : WADA, 2019.
- Report compiled based on cases received by WADA before 31 May 2019

This is the fifth year that WADA publishes the ADRVs Report. The Report illustrates doping offencescommitted under the World Anti-Doping Code (Code) in 2017.

The Report includes the decisions received by WADA before 31 May 2019 of all Adverse AnalyticalFindings (AAFs) for which the samples were collected by Anti-Doping Organizations (ADOs) in 2017and reported in ADAMS. This also includes Non-Analytical Anti-Doping rule violations for decisionsrendered in 2017. Discrepancy from ADOs’ published statistics may occur due to different reportingcriteria.

The ADRVs Report is divided as follows:

1.) An Introduction and an Executive Summary which provide an overview and highlight the key observations of the 2017 ADRVs Report.
2.) Sections 1 and 2 present the results management outcomes (including ADRVs) of all AAFs detected by WADA-accredited Laboratories for samples collected from athletes in- and out-of-competition in 2017. They are presented by sport, discipline (Section 1) and testing authority (Section 2).

3.) Section 3 includes ADRVs that resulted from Non-Analytical findings committed by Athletes (presented by sport and nationality) and by Athlete Support Personnel (presented by nationality).

4.) Section 4 indicates the total number of ADRVs from Athletes in 2017, which includes AAFs that resulted in an ADRV and all Non-Analytical ADRVs. The data is presented by sport andnationality.
The information is further divided into:
- Sample type (urine or blood),
- Type of test (in- or out-of-competition), and;
- Athlete gender.

Contents:

Introduction
Executive Summary
Section 1: Outcomes of 2017 AAFs by Sport Category
Section 2: Outcomes of 2017 AAFs by Testing Authority Category
Section 3: Report of 2017 Non-Analytical ADRVs
Section 4: Report of 2017 Total Analytical and Non-Analytical ADRVs

2017 Anti-Doping Testing Figures / World Anti-Doping Agency (WADA). - Montreal : WADA, 2018

Contents:

- Executive Summary - pp. 2-9 (7 pages)
- Laboratory Report -– pp. 10-36 (26 pages)
- Sport Report - pp. 37-158 (121 pages)
- Testing Authority Report - pp. 159-298 (139 pages)
- ABP Report-Blood Analysis - pp. 299-336 (37 pages)

2018 Anti-Doping Rule Violations (ADRVs) Report / World Anti-Doping Agency (WADA). - Montreal : WADA, 2020. - Report compiled based on decisions received by WADA before 2 March 2020

• The Report highlights 1,923 confirmed Anti-Doping Rule Violations (ADRVs) in 2018, involving individuals from 117 nationalities and across 92 sports
• 1,640 ADRVs came from Adverse Analytical Findings and 283 from non-analytical, evidence-based intelligence

The World Anti-Doping Agency (WADA) has publishes its sixth annual Anti-Doping Rule Violations (ADRVs) Report, which is the official set of such figures under the World Anti-Doping Code. As usual, the Report is available in a PDF version as well as a dynamic, Excel version that illustrates the ADRV results in an interactive fashion.

The Report illustrates doping offences committed in global sport during 2018. It highlights that there were a total of 1,923 ADRVs recorded in that year. This represents a 6.5% increase relative to the 2017 figure of 1,804, which in turn was 13% more than 2016.

1,640 of the ADRVs came out of Adverse Analytical Findings (AAFs), commonly known as ‘positive’ results. The remainder were derived from investigations and evidence-based intelligence into 267 violations committed by athletes and 16 by athlete support personnel (ASP).

The report contains all ADRV decisions reported to WADA by Anti-Doping Organizations (ADOs). These decisions include those from AAFs reported in samples collected by ADOs in 2018 as well as from non-analytical ADRV decisions rendered in 2018.

As with previous years, the beginning of the report comprises an introduction and an executive summary highlighting key data. The first and second sections present the Results Management outcomes (including ADRVs) of all AAFs detected by WADA-accredited Laboratories for samples collected in 2018 from athletes in- and out-of-competition. They are presented by sport, discipline (Section 1) and testing authority (Section 2).

Section 3 includes ADRVs that resulted from non-analytical findings committed by athletes (presented by sport and nationality) and by ASP (presented by nationality).

Section 4 indicates the total number of ADRVs in 2018, which includes AAFs that resulted in an ADRV plus all non-analytical ADRVs. It presents the data by sport and nationality. It is further broken down into type of samples (urine or blood), type of test (in- or out-of-competition) and athlete gender.

2018 Anti-Doping Testing Figures / World Anti-Doping Agency (WADA). - Montreal : WADA, 2019

Contents:

- Executive Summary - pp. 2-6 (5 pages)
- Laboratory Report -– pp. 7-34 (28 pages)
- Sport Report - pp. 35-159 (125 pages)
- Testing Authority Report - pp. 160-304 (145 pages)
- ABP Report-Blood Analysis - pp. 305-343 (39 pages)

2019 Anti-Doping Rule Violations (ADRVs) Report / World Anti-Doping Agency (WADA). - Montreal : WADA, 2021. - Report compiled based on decisions received by WADA before 31 January 2021

• The Report highlights 1,914 confirmed Anti-Doping Rule Violations in 2019, involving individuals from 117 nationalities and across 89 sports
• 1,537 ADRVs came from Adverse Analytical Findings and 377 from non-analytical, evidence-based intelligence

The World Anti-Doping Agency (WADA) has published its seventh annual Anti-Doping Rule Violations (ADRVs) Report, which is the official set of such figures under the World Anti-Doping Code. As usual, the Report is available in a PDF version as well as a dynamic, Excel version that illustrates the ADRV results in an interactive fashion.

The Report illustrates doping offences committed in global sport during 2019. It includes all decisions received by WADA’s Legal Affairs Department up to 31 January 2021. It highlights that there were a total of 1,914 ADRVs recorded in 2019. This represents a slight decrease relative to the 2018 figure of 1,923.

1,537 of the ADRVs came out of Adverse Analytical Findings (AAFs), commonly known as ‘positive’ results. The remainder were derived from investigations and evidence-based intelligence into 377 violations committed by athletes and athlete support personnel.

The 2019 Anti-Doping Rule Violations Report contains all ADRV decisions reported to WADA by Anti-Doping Organizations (ADOs). These decisions include those from AAFs reported in samples collected by ADOs in 2019 as well as from non-analytical ADRV decisions rendered in 2019.

As with previous years, the beginning of the report comprises explanations and definitions, an introduction and an executive summary highlighting key data. The first and second sections present the Results Management outcomes (including ADRVs) of all AAFs detected by WADA-accredited Laboratories for samples collected in 2019 from athletes in- and out-of-competition. They are presented by sport category (Section 1) and testing authority category (Section 2).

Section 3 includes ADRVs that resulted from non-analytical findings committed by athletes (presented by sport and nationality) and by athlete support personnel (presented by nationality).

Section 4 indicates the total number of ADRVs in 2019, which includes AAFs that resulted in an ADRV plus all non-analytical ADRVs. It presents the data by sport and nationality and is further broken down into type of samples (urine or blood), type of test (in- or out-of-competition) and athlete sex classification.
 

2019 Anti-Doping Testing Figures / World Anti-Doping Agency (WADA). - Montreal : WADA, 2020

Contents:

• Executive Summary - pp. 2-8 (7 pages)
• Laboratory Report -– pp. 9-37 (28 pages)
• Sport Report - pp. 38-174 (137 pages)
• Testing Authority Report - pp. 175-313 (139 pages)
• ABP Report-Blood Analysis - pp. 314-355 (42 pages)

Report Highlights

• A 5.5% increase in the overall number of samples analyzed: 263,519 in 2018 to 278,047 in 2019.
• A slight decrease in the total percentage of Adverse Analytical Findings (AAFs): 1.05% in 2018 (2,774 AAFs from 263,519 samples) to 0.97% in 2019 (2,702 AAFs from 278,047 samples).
• About 60% of WADA-accredited Laboratories saw an increase in the total number of samples recorded.
• An almost similar total number and percentage of non-Athlete Biological Passport (ABP) blood samples analyzed: 9.3% in 2018 (24,495 of 263,519) and 9.1% in 2019 (25,339 of 278,047).
• An increase of 16% in the number of ABP blood samples tested: 31,265 in 2018 to 36,401 in 2019.
• An increase in AAFs reported for Erythropoiesis Stimulating Agents (ESAs), Growth Hormone (GH) and Growth Hormone Releasing Factors (GHRFs).

The World Anti-Doping Agency (WADA) has published its 2019 Testing Figures Report (2019 Report), which summarizes the results of all the samples WADA-accredited Laboratories analyzed and reported in WADA’s Anti-Doping Administration and Management System (ADAMS) in 2019.

This is the fifth set of global testing figures under the version of the World Anti-Doping Code (Code) that came into effect in January 2015. The 2019 Report – which includes an Executive Summary and sub-reports by Laboratory, Sport, Testing Authority and Athlete Biological Passport (ABP) Blood Analysis – includes in- and out-of-competition urine samples; blood and ABP blood data; and, the resulting AAFs and Atypical Findings (ATFs).